This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Aharoni S, Sadeh M, Shapira Y, Edvardson S, Daana M, Dor-Wollman T, et al. Congenital myasthenic syndrome in Israel: Genetic and clinical characterization. Neuromuscul Disord. 2017; 27(2): 136-140.10.1016/j.nmd.2016.11.01428024842AharoniSSadehMShapiraYEdvardsonSDaanaMDor-WollmanTet alCongenital myasthenic syndrome in Israel: Genetic and clinical characterization2017272136140Open DOISearch in Google Scholar
Cruz PMR, Palace J, Beeson D. Congenital myasthenic syndromes and the neuromuscular junction. Curr Opin Neurol. 2014; 27(5): 566-575.10.1097/WCO.000000000000013425159927CruzPMRPalaceJBeesonDCongenital myasthenic syndromes and the neuromuscular junction2014275566575Open DOISearch in Google Scholar
Abicht A, Dusl M, Gallenmüller C, Guergueltcheva V, Schara U, Delia Marina A, et al. Congenital myasthenic syndromes: Achievements and limitations of phenotype guided gene after gene sequencing in diagnostic practice: A study of 680 patients. Hum Mutat. 2012; 33(10): 1474-1484.10.1002/humu.22130AbichtADuslMGallenmüllerCGuergueltchevaVScharaUDeliaMarina Aet alCongenital myasthenic syndromes: Achievements and limitations of phenotype guided gene after gene sequencing in diagnostic practice: A study of 680 patients2012331014741484Open DOISearch in Google Scholar
Beeson D. Congenital myasthenic syndromes: Recent advances. Curr Opin Neurol. 2016; 29(5): 565-571.2747250610.1097/WCO.0000000000000370BeesonDCongenital myasthenic syndromes: Recent advances2016295565571Search in Google Scholar
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7(4): 248-249.10.1038/nmeth0410-24820354512AdzhubeiIASchmidtSPeshkinLRamenskyVEGerasimovaABorkPet alA method and server for predicting damaging missense mutations201074248249Open DOISearch in Google Scholar
Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: Mutation prediction for the deep-sequencing age. Nat Methods. 2014; 11(4): 361-362.10.1038/nmeth.289024681721SchwarzJMCooperDNSchuelkeMSeelowDMutationTaster2: Mutation prediction for the deep-sequencing age2014114361362Open DOISearch in Google Scholar
Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003; 31(13): 3812-3814.10.1093/nar/gkg50912824425NgPCHenikoffSSIFT: Predicting amino acid changes that affect protein function2003311338123814Open DOISearch in Google Scholar
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5): 405-424.2574186810.1038/gim.2015.30RichardsSAzizNBaleSBickDDasSGastier-FosterJet alStandards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology2015175405424Search in Google Scholar
Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: The NCBI database of genetic variation. Nucleic Acids Res. 2001; 29(1): 308-311.1112512210.1093/nar/29.1.308SherrySTWardMHKholodovMBakerJPhanLSmigielskiEMet aldbSNP: The NCBI database of genetic variation2001291308311Search in Google Scholar
Abecasis GR, Altshuler D, Authon A, Brooks LD, Durbin RM, Gibbs RA; 1000 Genomes Project Consortium, et al. A map of human genome variation from population-scale sequencing. Nature. 2010; 467(7319): 1061-1073.AbecasisGRAltshulerDAuthonABrooksLDDurbinRMGibbsRA;1000Genomes Project Consortium, et al. A map of human genome variation from population-scale sequencing201046773191061107310.1038/nature09534Search in Google Scholar
Ohno K, Ohkawara B, Ito M. Recent advances in congenital myasthenic syndromes. Clin Exp Neuro-immunol. 2016; 7(3): 246-259.OhnoKOhkawaraBItoMRecent advances in congenital myasthenic syndromes20167324625910.1111/cen3.12316Search in Google Scholar
McMacken G, Abicht A, Evangelista Τ, Spendiff S, Lochmuller H, Soltanzadeh A. The increasing genetic and phenotypical diversity of congenital myasthenic syndromes. Neuropediatrics. 2017; 48(04): 294-308.2850567010.1055/s-0037-1602832McMackenGAbichtAEvangelistaΤSpendiffSLochmullerHSoltanzadehAThe increasing genetic and phenotypical diversity of congenital myasthenic syndromes20174804294308Search in Google Scholar
Soltanzadeh P, Müller JS, Ghorbani A, Abicht A, Lochmuller H, Soltanzadeh A. An Iranian family with congenital myasthenic syndrome caused by a novel acetylcholine receptor mutation (CHRNE K171X). J Neural Neurosurg Psychiatry. 2005; 76(7): 1039-1040.10.1136/jnnp.2004.059436SoltanzadehPMüllerJSGhorbaniAAbichtALochmullerHSoltanzadehAAn Iranian family with congenital myasthenic syndrome caused by a novel acetylcholine receptor mutation (CHRNE K171X)200576710391040Open DOISearch in Google Scholar
Natera-de Benito D, Dominguez-Carral J, Muelas N, Nascimento A, Ortez C, Jaijo T, et al. Phenotypic heterogeneity in two large Roma families with a congenital myasthenic syndrome due to CHRNE 1267delG mutation. A long-term follow-up. Neuro-muscul Disord. 2016; 26(11): 789-795.Natera-deBenito DDominguez-CarralJMuelasNNascimentoAOrtezCJaijoTet alPhenotypic heterogeneity in two large Roma families with a congenital myasthenic syndrome due to CHRNE 1267delG mutation2016261178979510.1016/j.nmd.2016.08.005Search in Google Scholar
Richard P, Gaudon K, Haddad H, Ammar AB, Genin E, Bauché S, et al. The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa. Neurology. 2008; 71(24): 1967-1972.10.1212/01.wnl.0000336921.51639.0b19064877RichardPGaudonKHaddadHAmmarABGeninEBauchéSet alThe CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa2008712419671972Open DOISearch in Google Scholar